Adcendo ApS Completes Oversubscribed $135 Million Series B Financing to Advance First-in-class ADC Pipeline
Adcendo, a biotech company focused on the development of first-in-class ADCs for the treatment of cancers with a high unmet medical need, today announced the successful closing of an oversubscribed ...
HORIZON PETROLEUM ANNOUNCES REINSTATEMENT AS A TIER 2 ISSUER ONTO THE TSX VENTURE EXCHANGE
The underlying securities are subject to a four month hold period from the original date of issue of the Subscription Receipts (hold period expires January 18, 2025 and March 1, 2025).‎ Following the ...